We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.06B
Turnover
46.34%
1-Year Est. Return
215.32%
This Fund
S&P 500
This Quarter
Est. Return
+18.8%
1 Year Est. Return
+215.32%
3 Year Est. Return
+310.3%
5 Year Est. Return
+497.45%
10 Year Est. Return
+14,692.23%
AUM
$2.68B
AUM Growth
+$421M
(+19%)
Cap. Flow
+$308M
Cap. Flow
% of AUM
11.53%
Top 10 Holdings %
Top 10 Hldgs %
68.02%
Holding
83
New
12
Increased
16
Reduced
6
Closed
11
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.9
years
Top 20 Avg Time Held Equity + Options
1.1
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alector
ALEC
|
+$68.6M |
| 2 |
Morphic Holding, Inc. Common Stock
MORF
|
+$52.4M |
| 3 |
Relay Therapeutics
RLAY
|
+$34.9M |
| 4 |
Arcus Biosciences
RCUS
|
+$32.5M |
| 5 |
Janux Therapeutics
JANX
|
+$31.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eledon Pharmaceuticals
ELDN
|
+$11.9M |
| 2 |
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
|
+$10.5M |
| 3 |
Neurogene
NGNE
|
+$8.45M |
| 4 |
AC Immune
ACIU
|
+$6.91M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.93% |
| 2 | Financials | 0.6% |
| 3 | Miscellaneous | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SNCE
76
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| – | – |
-2,825
| Closed | -$573K | – |
|
|
AMTI
77
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| – | – |
-239,443
| Closed | -$10.5M | – |
|
|
CDAK
78
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| – | – |
-115,195
| Closed | -$1.74M | – |
|
|
MTCR
79
DELISTED
Metacrine, Inc. Common Stock
MTCR
| – | – |
-62,207
| Closed | -$386K | – |
|
|
FLACU
80
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| – | – |
-200,000
| Closed | -$2.03M | – |
|
|
LOGC
81
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| – | – |
-688,700
| Closed | -$5.01M | – |
|
|
CHFW.U
82
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
| – | – |
-200,000
| Closed | -$1.95M | – |
|
83
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
| – | – |
-150,000
| Closed | -$2.9M | – |
|
Similar funds
RHJA
ST
ABTD
CFA
DWT
RMC
SIC
FWTB
EcoR1 Capital's Q2 2021 Portfolio in Review
As of Q2 2021, EcoR1 Capital held 83 positions worth $2.68B, up 19% from $2.25B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
EcoR1 Capital deployed $308M of net new capital in Q2 2021, opening 12 new positions and adding to 16 existing holdings. Its largest new stake was Janux Therapeutics: 1,411,975 shares worth $35.2M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Neurogene, an estimated $8.45M trimmed.
- EcoR1 Capital's largest Q2 2021 buy was Janux Therapeutics: 1,411,975 shares worth $35.2M.
- EcoR1 Capital added most to Alector in Q2 2021, an estimated $68.6M increase.
- EcoR1 Capital's biggest Q2 2021 reduction was Neurogene, cutting an estimated $8.45M.
- EcoR1 Capital fully exited Eledon Pharmaceuticals in Q2 2021, selling an estimated $11.9M.
- EcoR1 Capital's ten largest holdings make up 68% of its $2.68B portfolio in Q2 2021.
- EcoR1 Capital opened 12 new positions and closed 11 in Q2 2021.
- EcoR1 Capital's portfolio value rose 19% quarter-over-quarter to $2.68B.
Based on EcoR1 Capital's 13F filing for Q2 2021, filed 16 Aug 2021.